Back to top

Analyst Blog: Archive

Zacks Equity Research

Progressive's August Earnings Decrease, Revenues Rise Y/Y

Progressive's (PGR) August earnings reflect improvement in the top line offset by higher expenses.

PGR Y DGICA HALL

Zacks Equity Research

Why Should You Retain Centene (CNC) Stock in Your Portfolio?

Banking on a rising revenue base and an inorganic growth strategy, Centene (CNC) holds enough potential to reap benefits for investors.

WCG HUM CNC MOH

Zacks Equity Research

AstraZeneca's Farxiga Gets Fast Track Tag for Heart Failure

The FDA assigns a Fast Track status to AstraZeneca's (AZN) Farxiga to reduce the risk of cardiovascular death or worsening of heart failure in adult patients with HFrEF and HFpEF.

AZN JNJ BMY LLY

Zacks Equity Research

Alaska Air Group (ALK) Reports Impressive August Traffic

Alaska Air Group's (ALK) August load factor improves on the back of traffic growth surpassing capacity expansion.

ALK ALGT CPA VLRS

Zacks Equity Research

Take-Two's (TTWO) Borderlands 3 Launch Boosts Gaming Lineup

Take-Two (TTWO) is expected to benefit from portfolio strength with the launch of Borderlands 3 despite intensifying competition.

TTWO GLUU ATVI EA

Zacks Equity Research

Here's Why Hold Strategy is Apt for AXIS Capital (AXS) Now

AXIS Capital (AXS) remains poised for growth on solid performances across businesses and sound capital position.

DGICA HALL AXS PLMR

Zacks Equity Research

Akari's Nomacopan Gets Orphan Drug Tag for Rare Skin Disease

The FDA grants orphan drug status to Akari's (AKTX) nomacopan for the treatment of bullous pemphigoid, a severe blistering skin condition.

ACOR ALXN EMMA AKTX

Zacks Equity Research

GMS Surges 87% Year to Date: Can the Bull Run Continue?

Solid organic growth opportunities across GMS' existing platform and accretive acquisitions are likely to help it to grow further.

BLDR LOW GMS BMCH

Zacks Equity Research

Here's Why Investors Should Steer Clear of Red Rock Resorts

Red Rock Resorts' (RRR) bottom-line performance disappoints investors over the past two quarters. The company's price trend in the past six months is also worrisome.

RRR PENN SCPL MLCO

Zacks Equity Research

Biogen Stops Late-Stage Studies on Alzheimer's Candidate

Biogen (BIIB) and its Japanese partner, Eisai receive another setback as they discontinue two late-stage studies evaluating elenbecestat in patients with Alzheimer's disease.

NVS RHHBY AZN BIIB

Zacks Equity Research

Northrop Grumman Wins Deal to Build B-2 Trailing Edge Units

Northrop (NOC) to develop B-2 hot trailing edge production units.

NOC WAIR TDY LHX

Zacks Equity Research

Beacon Roofing Down 9% Over a Year: What's Hurting the Stock?

Lower demand and higher material prices are hurting Beacon Roofing Supply (BECN).

BECN BLDR BMCH GMS

Zacks Equity Research

Electronic Arts Expands Portfolio With the Release of NHL 20

Electronic Arts (EA) is expected to benefit from portfolio strength with the release of NHL 20 despite intensifying competition.

TTWO EA ATVI GLUU

Zacks Equity Research

Soft Carbohydrate Unit Hurts Archer Daniels: Will It Revive?

Archer Daniels (ADM) grapples with soft Carbohydrate Solutions segment. Nevertheless, its Readiness program looks encouraging.

CAG THS MGPI ADM

Maharathi Basu

5 Stocks in the Limelight After Recent Broker Rating Upgrade

Broker opinion acts as a valuable guide for investors while deciding their course of action on a particular stock.

AXE ACM BBY CVS ABC

Zacks Equity Research

Is Century Communities (CCS) A Suitable Pick for Value Investors?

Is Century Communities (CCS) a great pick from the value investor's perspective right now? Read on to know more.

CCS

Zacks Equity Research

Should Value Investors Pick Beazer Homes (BZH) Stock?

Is Beazer Homes (BZH) a great pick from the value investor's perspective right now? Read on to know more.

BZH

Zacks Equity Research

Here's Why You Should Retain Patterson Companies (PDCO) Now

Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts. However, intense competition remains a woe.

BAX HSIC PDCO CNMD

Zacks Equity Research

Can Value Investors Consider AECOM (ACM) a Profitable Pick?

AECOM (ACM) stock may be a good choice for value-oriented investors right now from multiple angles.

ACM

Shilpa Mete

Does JPMorgan's Same-Day Deposit Put PYPL & Others in Danger?

Digital payments space heats up with growing proliferation of instant and same-day deposit services being offered by JPMorgan Chase, Square, PayPal and others.

JPM PYPL SQ AAPL INTU

Zacks Equity Research

Qorvo's New FEM Module to Enhance Efficiency of IoT Devices

Qorvo's (QRVO) Expanding portfolio of 5G and GaN solutions hold promise. Further, robust growth in its wireless connectivity as well as in base station solutions is a positive.

FTNT QRVO AAPL SNPS

Tirthankar Chakraborty

American Shoppers Splurge, Keep Economy From Tanking

Buoyed by a resilient labor market and solid income gains, consumers remain the primary source of firepower for economic growth amid moribund factory output.

CRMT ABG STMP CASY RH

Zacks Equity Research

Is United Rentals (URI) a Worthy Pick for Value Investors?

United Rentals (URI) stock may be a good choice for value-oriented investors right now from multiple angles.

URI

Zacks Equity Research

Can Kimberly-Clark's Saving Plans Pare Input Cost Woes?

Kimberly-Clark (KMB) is on track with restructuring initiatives to boost savings and drive efficiency. However, rising input costs and sluggishness in the K-C Professional unit are headwinds.

KMB EL HSY CAG

Zacks Equity Research

Should Value Investors Pick Universal Forest Products (UFPI)?

Let's see if Universal Forest Products (UFPI) stock is a good choice for value-oriented investors right now from multiple angles.

UFPI